Society guideline links: Treatment and prevention of infective endocarditis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Sepsis in children and adults" and "Society guideline links: Outpatient parenteral antimicrobial therapy".)

Canada

●Choosing Wisely Canada: Don't prescribe aminoglycosides for synergy to patients with bacteremia or native valve infective endocarditis caused by Staphylococcus aureus (2022)

United States

●American Heart Association (AHA): Scientific statement on management of infective endocarditis in people who inject drugs (2022)

●American Academy of Pediatrics (AAP): Red Book – Prevention of bacterial endocarditis (2021)

●American College of Radiology (ACR): ACR Appropriateness Criteria on infective endocarditis (2020)

●AHA: Prevention of viridans group streptococcal infective endocarditis (2021)

●American College of Cardiology (ACC)/AHA: Guideline for the management of patients with valvular heart disease (2020)

●AHA: Scientific statement on infective endocarditis in adults – Diagnosis, antimicrobial therapy, and management of complications (2015)

●AHA: Scientific statement on infective endocarditis in childhood, update (2015)

●AHA: Scientific statement on cardiovascular implantable electronic device infections and their management, update (2010)